Reuters logo
BRIEF-Botanix Pharmaceuticals' acne treatment product gets FDA confirmation to support NDA
October 8, 2017 / 9:32 PM / 14 days ago

BRIEF-Botanix Pharmaceuticals' acne treatment product gets FDA confirmation to support NDA

Oct 9 (Reuters) - Botanix Pharmaceuticals Ltd

* Successfully held pre-Investigational New Drug meeting with FDA for its acne treatment product, BTX 1503 ​

* Gained confirmation from FDA on overall drug development plan required for BTX 1503 to support New Drug Application Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below